Selection of novel peptides homing alternative targets in triple negative breast cancer

[Excerpt] Breast cancer is the most frequent cancer amongst women, representing 25% of all cancer cases, with an estimated 1.67 million new cases in 2012 1. Phenotypically characterized by the lack of known receptors, the triple negative breast cancer (TNBC) subtype is responsible for 10 to 20% of a...

ver descrição completa

Detalhes bibliográficos
Autor principal: Ferreira, Débora (author)
Outros Autores: Silva, Vera Lúcia Domingues (author), Nóbrega, Franklin Luzia (author), Martins, Ivone M. (author), Kluskens, Leon (author), Rodrigues, L. R. (author)
Formato: conferenceObject
Idioma:eng
Publicado em: 2017
Assuntos:
Ciências Médicas::Biotecnologia Médica
Engenharia e Tecnologia::Biotecnologia Industrial
Texto completo:http://hdl.handle.net/1822/45086
País:Portugal
Oai:oai:repositorium.sdum.uminho.pt:1822/45086

Texto Completo

http://hdl.handle.net/1822/45086

Registos relacionados